Clinical Trials Browser

Phase 3 × Breast Neoplasms × Olanzapine × Clear all

NCT03367572 2025-09-25

Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

Phase 3 Completed

1,363 enrolled 20 charts

Breast Neoplasms

NCT02861859 2020-02-26

Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study

Phase 3 Completed

Breast Neoplasms